Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

241 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Central European Group on Genetics of Movement Disorders.
Ostrozovicova M, Dusek P, Grofik M, Han V, Holly P, Jech R, Klivenyi P, Kovacs N, Kulcsarova K, Kurca E, Lackova A, Magocova V, Necpal J, Pinter D, Ruzicka E, Serranova T, Smilowska K, Straka I, Svorenova T, Tamas G, Valkovic P, Zarubova K, Houlden H, Rizig M, Skorvanek M. Ostrozovicova M, et al. Among authors: klivenyi p. Eur J Neurol. 2024 Apr;31(4):e16165. doi: 10.1111/ene.16165. Epub 2023 Dec 7. Eur J Neurol. 2024. PMID: 38059386 Free PMC article. No abstract available.
Cladribine tablets in people with relapsing multiple sclerosis: A real-world multicentric study from southeast European MS centers.
Adamec I, Brecl Jakob G, Rajda C, Drulović J, Radulović L, Bašić Kes V, Lazibat I, Rimac J, Cindrić I, Gržinčić T, Abičić A, Barun B, Gabelić T, Gomezelj S, Mesaroš Š, Pekmezović T, Klivényi P, Krbot Skorić M, Habek M. Adamec I, et al. Among authors: klivenyi p. J Neuroimmunol. 2023 Sep 15;382:578164. doi: 10.1016/j.jneuroim.2023.578164. Epub 2023 Jul 27. J Neuroimmunol. 2023. PMID: 37536052
NEDA-state, psychological symptoms and quality of life are stable in natalizumab-treated multiple sclerosis patients: An up to 6-years long follow-up study.
Sandi D, Kokas Z, Kincses ZT, Füvesi J, Fricska-Nagy Z, Vörös E, Biernacki T, Vécsei L, Klivényi P, Bencsik K. Sandi D, et al. Among authors: klivenyi p. Heliyon. 2024 Oct 18;10(20):e39536. doi: 10.1016/j.heliyon.2024.e39536. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39502229 Free PMC article.
ChatGPT M.D.: Is there any room for generative AI in neurology?
Nógrádi B, Polgár TF, Meszlényi V, Kádár Z, Hertelendy P, Csáti A, Szpisjak L, Halmi D, Erdélyi-Furka B, Tóth M, Molnár F, Tóth D, Bősze Z, Boda K, Klivényi P, Siklós L, Patai R. Nógrádi B, et al. Among authors: klivenyi p. PLoS One. 2024 Oct 9;19(10):e0310028. doi: 10.1371/journal.pone.0310028. eCollection 2024. PLoS One. 2024. PMID: 39383119 Free PMC article.
p.L1795F LRRK2 variant is a common cause of Parkinson's disease in Central Europe.
Ostrozovicova M, Tamas G, Dušek P, Grofik M, Han V, Holly P, Jech R, Kalinova K, Klivenyi P, Kovacs N, Kulcsarova K, Kurca E, Lackova A, Lee H, Lewis P, Magocova V, Marekova M, Murphy D, Necpal J, Pinter D, Rabajdova M, Růžička E, Serranova T, Smilowska K, Soos K, Straka I, Svorenova T, Valkovic P, Zarubova K, Gdovinova Z, Houlden H, Rizig M, Skorvanek M. Ostrozovicova M, et al. Among authors: klivenyi p. Res Sq [Preprint]. 2024 May 29:rs.3.rs-4378197. doi: 10.21203/rs.3.rs-4378197/v1. Res Sq. 2024. PMID: 38854119 Free PMC article. Preprint.
241 results